Back
Reneo Pharmaceuticals Stock Price Chart
Sponsored
RPHM
Sponsored
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Sell
23
RPHM
Reneo Pharmaceuticals
Last Price:
1.50
Seasonality Move:
-26.13%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RPHM is experiencing slight buying pressure.
Reneo Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.41 | Buy |
20-day SMA: | 1.47 | Buy |
50-day SMA: | 1.47 | Buy |
200-day SMA: | 1.85 | Sell |
8-day EMA: | 1.42 | Buy |
20-day EMA: | 1.44 | Buy |
50-day EMA: | 1.48 | Buy |
200-day EMA: | 2.31 | Sell |
Reneo Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 55.1 | Buy |
Chaikin Money Flow: | 264572 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.4 - 1.56) | Buy |
Bollinger Bands (100): | (1.44 - 1.7) | Sell |
Reneo Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Reneo Pharmaceuticals Stock
Is Reneo Pharmaceuticals Stock a Buy?
- Reneo Pharmaceuticals share price is 1.50 while RPHM 8-day simple moving average is 1.41, which is a Buy signal.
- The stock price of RPHM is 1.50 while Reneo Pharmaceuticals 20-day SMA is 1.47, which makes it a Buy.
- Reneo Pharmaceuticals 50-day simple moving average is 1.47 while RPHM share price is 1.50, making it a Buy technically.
- RPHM stock price is 1.50 and Reneo Pharmaceuticals 200-day simple moving average is 1.85, creating a Sell signal.
RPHM Technical Analysis vs Fundamental Analysis
Sell
23
Reneo Pharmaceuticals (RPHM)
is a Sell
Is Reneo Pharmaceuticals a Buy or a Sell?
-
Reneo Pharmaceuticals stock is rated a Sell
The current Reneo Pharmaceuticals [RPHM] share price is $1.50. The Score for RPHM is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Reneo Pharmaceuticals Stock Info
Market Cap:
50.14M
Price in USD:
1.50
Share Volume:
727.57K
Reneo Pharmaceuticals 52-Week Range
52-Week High:
9.21
52-Week Low:
0.98
Sell
23
Reneo Pharmaceuticals (RPHM)
is a Sell
Reneo Pharmaceuticals Share Price Forecast
-
What is the Reneo Pharmaceuticals stock price today?
The Reneo Pharmaceuticals stock price is 1.50 USD today. -
Will RPHM stock go up or go down?
Reneo Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Reneo Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Reneo Pharmaceuticals is overvalued.
Is Reneo Pharmaceuticals Stock a Buy?
- Reneo Pharmaceuticals share price is 1.50 while RPHM 8-day exponential moving average is 1.42, which is a Buy signal.
- The stock price of RPHM is 1.50 while Reneo Pharmaceuticals 20-day EMA is 1.44, which makes it a Buy.
- Reneo Pharmaceuticals 50-day exponential moving average is 1.48 while RPHM share price is 1.50, making it a Buy technically.
- RPHM stock price is 1.50 and Reneo Pharmaceuticals 200-day simple moving average is 2.31, creating a Sell signal.
Fundamental Analysis of Reneo Pharmaceuticals
Is Reneo Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.53 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and a decrease next year of $0.04 per share.
Technical Analysis of Reneo Pharmaceuticals
Should I short Reneo Pharmaceuticals stock?
- RPHM Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Reneo Pharmaceuticals is a Sell
- Reneo Pharmaceuticals Relative Strength Index (RSI) is 55.1, which suggest Reneo Pharmaceuticals is overbought
- The Bollinger Bands (25) for Reneo Pharmaceuticals is (1.4 - 1.56), which suggest Reneo Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Reneo Pharmaceuticals is (1.44 - 1.7), which suggest Reneo Pharmaceuticals is a Sell
* Reneo Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.